SCHEMBL16629847

SCHEMBL16629847

CCc1csc(-c2cccc(Cl)c2Cl)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
TDP1 Q9NUW8 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
HTR2C P28335 6/20 0.48
PANK3 Q9H999 1/20 0.47
TLR7 Q9NYK1 1/20 0.45
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
RAB9A P51151 1/20 0.42
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
LMNA P02545 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PTPN11 Q06124 2/20 0.39
KCNH2 Q12809 1/20 0.39
CDC7 O00311 1/20 0.39
DBF4 Q9UBU7 1/20 0.39
GFER P55789 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015824 0.87 ALDH1A1 (0.73) ALDH1A1TDP1L3MBTL1HTR2CKDM4E
SCHEMBL18014797 0.83 ALDH1A1 (0.51) ALDH1A1TDP1L3MBTL1HTR2CPANK3
SCHEMBL22792104 0.79 KDM4E (0.57) ALDH1A1TDP1L3MBTL1HTR2CPANK3
SCHEMBL6226222 0.75 ALDH1A1 (0.47) ALDH1A1TDP1L3MBTL1KDM4ENPC1
SCHEMBL18015816 0.74 L3MBTL1 (0.69) ALDH1A1TDP1L3MBTL1HTR2CKDM4E
SCHEMBL20255689 0.74 SHMT1 (0.55) ALDH1A1TDP1L3MBTL1TLR7KDM4E
SCHEMBL10062532 0.74 RAB9A (0.48) ALDH1A1TDP1L3MBTL1KDM4ENPC1
SCHEMBL5023376 0.73 LMNA (0.56) TDP1L3MBTL1TLR7KDM4ENPC1
SCHEMBL20255498 0.72 SHMT2 (0.70) ALDH1A1HTR2CPANK3TLR7KDM4E
SCHEMBL18015818 0.72 TDP1 (0.44) ALDH1A1TDP1L3MBTL1HTR2CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2016-08-11 US disclosed
WO-2015049616-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER INC. (US) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS BACE1, BACE2, PSEN2 ALDH1A1 1923/4885TDP1 860/4885L3MBTL1 4677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.